患者来源类器官生物样本库揭示肠道上皮MHC-I表观遗传失调是严重克罗恩病的新机制
研究构建168例患者(CD 72例、UC 23例、健康对照73例)的312个肠道上皮类器官,整合DNA甲基化与转录组分析,发现CD相关MHC-I位点DNA甲基化缺失及NLRC5上调,与疾病表型和结局相关,并建立预后表观遗传分子标签。
要点
- CD患者肠道上皮类器官存在MHC-I位点DNA甲基化缺失及NLRC5等基因上调。
- NLRC5缺陷小鼠对DSS结肠炎相对保护,支持MHC-I的功能作用。
- 类器官MHC-I DNA甲基化与CD疾病表型和结局显著相关。
核心结论
- 研究识别出表观遗传调控的肠道上皮MHC-I是克罗恩病发病的新机制。
研究设计与样本
- 从168例患者(CD 72例、UC 23例、健康对照73例)的黏膜活检组织构建312个肠道上皮类器官(IEO)。
- 进行全基因组DNA甲基化、bulk及单细胞RNA测序,并采用基因编辑、类器官-淋巴细胞共培养和NLRC5敲除小鼠DSS结肠炎模型进行功能验证。
主要发现
- 发现CD相关的MHC-I位点(包括NLRC5)DNA甲基化稳定缺失及相应基因上调。
- 原代黏膜组织和IEO的单细胞RNA测序证实NLRC5在肠道上皮中作为转录反式激活因子。
- 在成人和儿童CD患者中验证了黏膜MHC-I和NLRC5表达增高,NLRC5缺陷小鼠显示对DSS介导的黏膜炎症相对保护。
- IEO中MHC-I DNA甲基化与CD疾病表型和结局显著相关,机器学习方法构建了疾病预后表观遗传分子标签。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Epigenetic mechanisms, including DNA methylation (DNAm), have been proposed to play a key role in Crohn's disease (CD) pathogenesis. However, the specific cell types and pathways affected as well as their potential impact on disease phenotype and outcome remain unknown. We set out to investigate the role of intestinal epithelial DNAm in CD pathogenesis. DESIGN: We generated 312 intestinal epithelial organoids (IEOs) from mucosal biopsies of 168 patients with CD (n=72), UC (n=23) and healthy controls (n=73). We performed genome-wide molecular profiling including DNAm, bulk as well as single-cell RNA sequencing. Organoids were subjected to gene editing and the functional consequences of DNAm changes evaluated using an organoid-lymphocyte coculture and a nucleotide-binding oligomerisation domain, leucine-rich repeat and CARD domain containing 5 (NLRC5) dextran sulphate sodium (DSS) colitis knock-out mouse model. RESULTS: We identified highly stable, CD-associated loss of DNAm at major histocompatibility complex (MHC) class 1 loci including NLRC5 and cognate gene upregulation. Single-cell RNA sequencing of primary mucosal tissue and IEOs confirmed the role of NLRC5 as transcriptional transactivator in the intestinal epithelium. Increased mucosal MHC-I and NLRC5 expression in adult and paediatric patients with CD was validated in additional cohorts and the functional role of MHC-I highlighted by demonstrating a relative protection from DSS-mediated mucosal inflammation in NLRC5-deficient mice. MHC-I DNAm in IEOs showed a significant correlation with CD disease phenotype and outcomes. Application of machine learning approaches enabled the development of a disease prognostic epigenetic molecular signature. CONCLUSIONS: Our study has identified epigenetically regulated intestinal epithelial MHC-I as a novel mechanism in CD pathogenesis.
引用
- Dennison TW, Edgar RD, Payne F, et al. Patient-derived organoid biobank identifies epigenetic dysregulation of intestinal epithelial MHC-I as a novel mechanism in severe Crohn's Disease. Gut. 2024. PMID: 38857990. doi:10.1136/gutjnl-2024-332043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。